
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Infosys shares fell after Q4 FY26 results as FY27 constant-currency revenue guidance of 1.5% to 3.5% and softer deal metrics drove target cuts by brokerages.
Infosys declared a final dividend of ₹25 per share for FY26, setting June 10, 2026 as the record date, which could pay Ekagrah Murty ₹3.75 crore.
IDFC First Bank shifted its Q4 FY26 investor call to April 25, 2026 at 5 pm IST, sharing dial-in access details and post-call replay plans.
Cipla shares fell after the US FDA issued an official action indicated status to Pharmathen, its exclusive lanreotide supplier, raising fresh concerns over US supply and margins.
Reliance Industries reports Q4 FY26 results on April 24, with margins pressured by West Asia disruptions as investors track dividend signals and Jio IPO-related commentary.
Hindustan Zinc will announce Q4 and FY26 results on April 24, 2026, and its board may consider the first interim dividend for FY27, alongside an earnings call at 4 pm.
Modern Times Group’s India unit PlaySimple Games has filed its DRHP for a Rs 3,150 crore Mumbai IPO, structured as a pure offer-for-sale with no fresh issue.
Infosys beat profit estimates in Q4FY26, but brokerages flagged its FY27 constant-currency revenue guidance of 1.5-3.5% as a demand warning and cut targets.
Mojtaba Khamenei’s statements rejecting de-escalation, reporting on casualties and strikes, and India’s safety concerns for citizens in the Gulf highlight how the conflict is widening.
Reliance Industries shares weakened amid Middle East tensions, but analysts say a sharp jump in diesel crack spreads and steadier petrochemical economics could support near-term profits.
Morgan Stanley flagged stronger gross FDI into India but weak net inflows as repatriation rises, with services leading and manufacturing broadening into autos and electronics.
Lux Industries, up 112% in April and last seen 10% higher at ₹1,756.40, has approved an in-principle demerger into three verticals, subject to approvals.
Sun Pharma has submitted a binding all-cash offer for Organon, with bank financing largely aimed at debt refinancing, as it seeks a bigger branded and innovation-led portfolio.
Delta Corp surged 20% to Rs 81.45, extending a 31.92% two-session rally as investors tracked a dividend call, promoter buying, and key technical levels.
Indian solar stocks fell after the US imposed 126% preliminary countervailing duties, though Waaree’s clarification on cell-origin rules narrowed perceived impact as investors awaited next month’s dumping decision.
Reliance Industries is set to announce Q4 FY26 results on April 24, with investors tracking dividend plans, O2C margin pressure, and growth in Jio and retail.